Upload
hassan-ahmad
View
409
Download
1
Embed Size (px)
Citation preview
SKELETAL MUSCLE RELAXANTS &
SPASMOLYTICSBy
Dr. Abdul Azeem
I) PERIPHERALLY ACTING1) NEUROMUSCULAR JUNCTION BLOCKERS
a) NON DEPOLARIZING NEUROMUSCULAR BLOCKERS
ISOQUINOLINE DERIVATIVES
D- TUBOCURARINE
GALLAMINE
ATRACURIUM
CIS ATRACURIUM
ALCURIUM
DOXACURIUM
MIVACURIUM
• STEROID DERIVATIVES
PANCURONIUM
VECURONIUM
RAPACURONIUM
PIPECURONIUM
ROCURONIUM
b) DEPOLARIZING NEUROMUSCULAR BLOCKERS
SUXAMETHONIUM (SUCCINYLCHOLINE)
DECAMETHONIUM
2) DIRECTLY ACTING
DANTROLENE
II) CENTRALLY ACTING MUSCLE RELAXANTS (SPASMOLYTICS)
• BENZODIAZEPINES DIAZEPAM CHLORDIAZEPOXIDECLONAZEPAM NITRAZEPAM
• GABA ANALOGUES BACLOFEN PROGABIDE
oALPHA 2 AGONIST TIZANIDINE
OTHERSGLYCINE
MEPROBAMATE
MEPHENESEN
IDROCILAMIDE
RILUZOLE
BOTULINUM TOXIN
NEUROMUSCULAR JUNCTION BLOCKERS Classification according to duration of action
› Short acting Succinylcholine <8 min Mivacurium 10-20 min
› Intermediate acting Atracurium 25-35 min Cisatracurium 25-40 min Rocuronium 25-35 min Vecuronium 25-35 min
Long acting Doxacurium more than 35 min Tubocurarine more than 35 min Pancuronium more than 35 min Pipecuronium more than 35 min
Nicotinic Transmission At NMJ
NEUROMUSCULAR JUNCTION
NICOTINIC ACETYLCHOLINE RECEPTOR
History
Strychnos toxifera
Chemistry
• Pharmakokinetics
MOANon Depolarizing / Competitive N.M Blockers- Tubocurarine etc.
Mechanism of Action:
Non Depolarizing / Competitive N.M Blockers i.e . Tubocurarine etc.
Competitive antagonist to Ach at Nicotinic (Nm) Receptor at MEP
N.M Transmission is interrupted leading to N.M. Blockade.
At Larger doses, some drugs also enter pore of ion channel of Nm ,
further decrease in N.M. Transmission.
Blockade is:
Antagonised by:
Anticholinesterases (Neostingmine, Edrophonium,
Pyridostigmine )
Potentiated by:-
• GA.(Ether, Enflurane, Halothane)
• Amino glycoside Antibiotics. (Streptomycin, Gentamicyn)
• Acidosis
• L.A (Procaine)
• Hypokalemia
• Myasthenia gravis
• Dehydration
• Advanced age-Prolonged Effect
D-TUBOCURARINE (PROTOTYPE)
Non depolarizing N.M. Blocker.
Source:
Chief alkaloid of curare Obtained from
Chondrodendron & Strychnos
Chemistry:
Mono quaternary Ammonium Compound.
Pharmacokinetics: Not Abs. from GIT. Given I/VIt is redistributed. Not metabolised.Excreted unchanged by kidney 40 % / Bile 60
%Crosses Placenta but not harmful.It does not cross BBB.
Mechanism of action: O.O.A : 4 min.D.OA: more than 35 min
Pharmacological effects No central effects Skeletal muscle relaxation. First weakness & then
paralysis. Sequence of Paralysis of Skeletal Muscles:
Eye, Jaw, Facial muscles .Muscles of Neck, Limbs , Trunk.Interocostal musclesDiaphragmRecovery in reverse order.Ganglionic blockade: Mild in high doses
CVS: Hypotension due to
Release of Histamine.Vasodilatation, decreased PR , decreased BP. Bronchoconstriction due to Histamine release
Ganglionic Blockade (Vasodilatation) in larger doses.
PANCURONIUM
› Steroidal quaternary ammounioum compund › 6 times more potent than Tubocurarine› Quick onset of action› No effect on ganglia› Vagolytic effect› Moderate increase in Blood Pressure › No effect on CNS› No effect on foetus › No Histamine release› ›
• ATRACURIUM • Isoquinoline• Intermediate acting • Metabolism – Hepatic
• Hofmann Elimination • Laudanosine
Seizures
• Cis-Atracurium • Mivacurium: Shortest duration of action. Metabolised
by pseudocholine esterase
Depolarizing Skeletal Muscle Relaxant (Succinylcholine)
• Pharmakokinetics
M.O A of Depolarizing drugs (Succinylcholine)The Blockade occurs in 2 Phases
Phase I (depolarizing)
Phase I block: is augmented by anticholinestrase & not reversed
Phase I (depolarizing)1. Succinylcholine reacts with nicotinic receptors2. Ion channels are opened → depolarization of motor end
plate.3. Depolarization spreads to adjacent membrane 4. Result in disorgansed / generalized contraction of motor
unit.5. Not hydrolyzed in synapse → persistent depolarization
→ flaccid paralysis
Phase II Block (Desensitizing Block)With continued exposure—Initial end plate depolarization decreases and membrane is re polarized but unresponsive/ desensitized to Ach. due to:
Blockade of channel.Development of in excitable area in muscle membrane immediately
surrounding the M.E.P which prevent the spread of impulses or desensitization of membrane occurs .
MOA OF SUCCINYLCHOLINE
SUCCINYLCHOLINE › Hydolysed by plasma & liver Pseudochlone & butyryl
cholinesterases› Duration of action is very short (8 min)
DIBUCAINE NUMBER TEST
Adverse Effects• Non Depolarising Drugs
• Histamine Release• Vagolytic Effect
• Depolarising Drugs (Succinyl choline)• Malignant Hyperthermia• Apnea• Hyperkalamia • Increased intra gastric pressure• Increased IOP• Muscular Aches & Pain
•
Drug Interactions
• Uses of NMJ Blockers • Surgical operations • Endotracheal intubation ,laryngoscopy• Orthopedic manipulation • Convulsive disorders• Electroconvulsive therapy (ECT)• For assisted ventilation
SUGAMMADEX
When given post operatively there is rapid recovery from
even profound degree of Neuro muscular blockade.
It rapidly inactivate the steroidal neuro muscular blocking
drugs by forming an in active complex which is excreted in
urine
DANTROLENE MOA: It reduces the release of activator calcium from the
sarcoplasmic reticulum
DANTROLENE MOA
PHARMACOKINETICS
ADVERSE EFFECTS
THERAPEUTICS USES Spasmolytic Malignant hyperthermia
DOSE
PHARMACOKINETICS1/3 of oral dose is absorbed t ½ is 8 hrs.
ADVERSE EFFECTS •Muscle Weakness•Sedation •Occasionally hepatitis
THERAPEUTICS USES Spasmolytic Malignant hyperthermia
DOSE:As SpasmolyticInitially 25mg / day gradually increase over 7 weeks to a maximum of 100 mg 4 times a dayFor Malignant Hyperthemia
Botulinum ToxinMOA
Uses
Strabismus
Blepharospasm
Hemifacial spasm Spasm associated with lower esophageal sphincter and anal fissure
Dystonias e.g. cervical dystonia,Oromandibular dystonia
Generalized spastic disorders( cerebral palsy)
Hyperhidrosis of palms and axillae
Cosmetic procedure for wrinkles of the face
Central Spasmolytics • Spasticity is increased muscle tone. • increase in tonic stretch reflexes and flexor muscle spasm with muscle
weakness • Often observed in
– Cerebral palsy – Multiple sclerosis – Stroke – ALS (Amyotrophic lateral sclerosis)
• Aim• Reduction of excessive skeletal muscle tone without reduction of muscle
strength.
DIAZEPAM
MOA: It facilitates the action of GABA in CNS.
USES: Muscle Spasm (local truma to tetanus)
DOSE: Oral dose initially 5 mg / day and gradually increase to
maximum of 60 mg / day.
ADVERSE EFFECTS Sedation
BACLOFEN MOA: GABA B Agonist ADVERSE EFFECTS• Drowsiness• Increase in seizure activity in epileptic patients• Excessive somnolence• Respiratory depression• Coma THERAPEUTICS USES
– Relieves muscles spasm. Most useful agent for symptomatic treatment of spasticity
– Prevention of migraine – Reduces craving in recovering alcoholics
TIZANIDINE MOA: Centrally acting Alpha 2 agonist Inhibits release of excitatory amino acids in the
spinal interneuronsIt re-inforces both pre-synaptic & post- synaptic inhibition in the cord
ADVERSE EFFECTS Drowsiness Hypotension Dry mouth Asthenia
GABAPENTIN Antiepileptic drug is a good spasmolytic agent in patient
with multiple sclerosis
PRE GABALIN Newer analogue of gabapentin usefull in muscle spasm
PROGABIDE Gaba A and Gaba B agonist and has active metabolites
including GABA itself
Riluzole • Pharmacokinetics – Absorption orally – Highly protein bound – Half life 12 hours –Metabolism --- in liver by both cyotchrome P450-mediated hydroxylation and
glucurnidation MOA– it inhibits glutamate release – It also blocks postsynaptic NMDA- and kainite-type glutamate receptors and
inhibits voltage-dependent sodium channels
Uses • ALSDose• 50 mg every 12 hours Adverse effect • Nausea • Diarrhea • Hepatic injury
GLYCINE inhibitory neurotransmitter. When Given crosses
BBB IDROCILAMIDE
Newer drugs for treatment of ALS MOA
Inhibit glutamatergic transmission in CNS
Meprobamate • Seditive, Hypnotic and Anti anxiety drug
Carisoprodal • Its active metabolite is meprobamate. Cyclobenzaprine
DIAZEPAMMOA
USES
DOSE
ADVERSE EFFECTS
BACLOFEN MOA
ADVERSE EFFECTS
THERAPEUTICS USES– Relieves muscles spasm. Most useful agent for
symptomatic treatment of spasticity – Prevention of migraine –Reduces craving in alcoholics
TIZANIDINE MOA
It re-inforces both pre-synaptic & post- synaptic inhibition in the cord
ADVERSE EFFECTS Drowsiness Hypotension Dry mouth Asthenia
Meprobamate • Saditive, Hypnotic and Anti anxiety drug
Carisoprodal • Its active metabolite is meprobamate.
Glycine